| 000 | 01848cam a2200349 a 4500 | ||
|---|---|---|---|
| 003 | EG-GiCUC | ||
| 005 | 20250223030702.0 | ||
| 008 | 121009s2012 ua d f m 000 0 eng d | ||
| 040 |
_aEG-GiCUC _beng _cEG-GiCUC |
||
| 041 | 0 | _aeng | |
| 049 | _aDeposite | ||
| 097 | _aM.Sc | ||
| 099 | _aCai01.11.04.M.Sc.2012.Ib.E | ||
| 100 | 0 | _aIbrahim Mohammed Hamood Ali | |
| 245 | 1 | 0 |
_aEffect of diabetes mellitus and fibrinogen level on platelet inhibition with clopidogrel therapy / _cIbrahim Mohammed Hamood Ali ; Supervised Zeinab Attia Ashour , Amr Hassan Mostafa , Maguib Zoheir Mostafa |
| 246 | 1 | 5 | _aتأثير مرض السكرى و مستوى الفيبرينوجين على تثبيط الصفائح الدموية مع العلاج بعقار كلوبيدوجريل |
| 260 |
_aCairo : _bIbrahim Mohammed Hamood Ali , _c2012 |
||
| 300 |
_a115 P. : _bcharts ; _c25cm |
||
| 502 | _aThesis (M.Sc.) - Cairo University - Faculty of Medicine - Department of Cardiology | ||
| 520 | _aThe goal of this study was to identify factors associated with higher platelet aggregation following clopidogrel therapy in subjects with acute coronary syndrome(ACS). A heterogeneous platelet reactivity response to clopidogrel exists, and the clinical or biochemical predictors of suboptimal platelet inhibition with clopidogrel remain unclear. This study was conducted on 62 subjects with ACS requiring treatment with clopidogrel 75 mg daily for 7 days or more | ||
| 530 | _aIssued also as CD | ||
| 653 | 4 | _aACS | |
| 653 | 4 | _aClopidogrel therapy | |
| 653 | 4 | _aFibrinogen | |
| 700 | 0 |
_aAmr Hassan Mostafa , _eSupervisor |
|
| 700 | 0 |
_aMaguib Zoheir Mostafa , _eSupervisor |
|
| 700 | 0 |
_aZeinab Attia Ashour , _eSupervisor |
|
| 856 | _uhttp://172.23.153.220/th.pdf | ||
| 905 |
_aNazla _eRevisor |
||
| 905 |
_aSamia _eCataloger |
||
| 942 |
_2ddc _cTH |
||
| 999 |
_c39799 _d39799 |
||